|
TRENTON, NJ (May 16, 2024) – BioNJ's 14th Annual BioPartnering Conference was held on Tuesday, May 14, at its new venue, the Liberty Science Center in Jersey City. The Conference drew a crowd of 600 from 22 states, D.C., and 9 countries.
“The Liberty Science Center proved to be the perfect venue for the Conference,” stated BioNJ President and CEO, Debbie Hart. “The modern, state-of-the-art facility epitomizes innovation, fostering a kinetic atmosphere, providing a backdrop for lively discussion and productive dialogue.”
Sponsored by J.P. Morgan, Johnson & Johnson and Morgan Lewis and Jersey City Economic Development Corp., the Conference brought together entrepreneurs, life sciences executives, investors, strategics, academic collaborators and business development professionals for an action-packed day which included plenary sessions, partnering meetings, exhibits, company pitch presentations and lots of networking!
Attendees also had the opportunity to book 15-minute appointments at the highly sought-after Industry Connections Desk, providing exclusive one-on-one sessions with Business Development professionals from major biopharmaceutical firms including Ferring Pharmaceuticals, Johnson & Johnson, Merck & Co., Pfizer, Sanofi and Teva Pharmaceuticals.
Additionally, beyond the in-person partnering sessions on Tuesday, one-on-one partnering meetings will continue virtually throughout the week. Nearly 550 meetings are expected to take place throughout the week.
The full-day program included nearly 90 pitch presentations from innovative companies across life science, biotech, healthcare and digital health sectors. Each presentation was judged in five categories, culminating with an awards ceremony at the close of the day.
Congratulations to:
| |
|
Most Memorable Presenter
Award winner Mark Esposito, Ph.D., Vice President, R&D, Kayothera (center); who was joined (from left) by Pavita Howe, VP, Innovation & Entrepreneurship, BioNJ; David Schwartz, Partner, Morgan Lewis; Rachel Barreto; Regional Director, Datasite; Debbie Hart, BioNJ
| |
|
Most Inspiring Presentation
Award winner Kubi Turkmen, CEO, TelomEye (center); who was joined (from left) by Mike Wiley, Vice President, Foundation Venture Capital Group; Tingting Zhang-Kharas, Ph.D., Head, JLabs Northeast; Debbie Hart, BioNJ; Pavita Howe; BioNJ
| |
|
Most Unique Innovation
Jim Gunton, Managing Partner, Tech Council Ventures (second from right), accepting on behalf of EpiBone; who was joined (from left) by Pavita Howe; BioNJ; Michael Russo, Partner, CFGI; Rosemary McFadden, Chair, Jersey City Economic Development Corp.; Debbie Hart, BioNJ;
| |
|
Best Start-Up Pitch
Award Winner Adam Salamon, CEO, Pression (second from right); who was joined (from left) by Pavita Howe; BioNJ; Kathleen Addison, Executive Director, Life Sciences, J.P. Morgan; Paul Howard, Ph.D., Senior Director, Public Policy, Amicus Therapeutics; Debbie Hart, BioNJ
| |
|
Best Company Presentation
Award Winner Hanne Noyen, Scientific Liaison Manager, Ziphius (center); who was joined (from left) by Pavita Howe; BioNJ; Paul Hoffman, President & CEO, Liberty Science Center; Taryn Bostjancic, Practice Leader, Life Sciences, Withum; Debbie Hart, BioNJ
| |
“The mission of the BioPartnering Conference is to cultivate the ecosystem and foster partnerships that propel medical innovation forward,” added Hart. “The energy throughout the day as new opportunities and business endeavors were discussed was absolutely palpable. We extend our heartfelt gratitude to our planning team, sponsors, speakers, judges, coaches, reviewers, company pitch presenters and exhibitors for their invaluable contributions in making this event a resounding success.” | |
|
Lastly, thank you to Newsweek who was on hand for the roll out of its hot-off-the press “New Era of Life Sciences 2024 Report,” featuring many BioNJ Member companies. Click here for a copy of the Report.
Visit www.BioNJ.org for more information about BioNJ and our upcoming calendar of events.
| |
Thank You to Our Sponsors | |
Thank You to Our Supporting Partners | | | | |
